Navigation Links
Vyopta Granted Cisco Preferred Solution Developer Partner Status, Highest Level for Cisco Developer Network
Date:3/11/2013

Austin, Texas (PRWEB) March 11, 2013

To take advantage of the benefits of the expanding role of the network, Vyopta Incorporated, the leading developer of business intelligence and process automation applications for video collaboration, today announced that it is now a Preferred Solution Developer within the TelePresence and Collaboration technology category of Cisco’s Developer Network Program.

Vyopta software applications (vAnalytics™, vAccess™, vPublish™, vSchedule™ and vControl®) fuse business video products into end-to-end solutions that transform the way companies utilize video. Vyopta solutions set the standard in quality, scalability and robust capabilities to support a variety of customer use cases, from automation and management of workflows for video collaboration, lecture capture and publishing, to powerful business analytics that transform the way companies measure the impact of video on their business.

The Cisco Developer Network unites Cisco with third-party developers of hardware and software to deliver tested interoperable solutions to joint customers, harnessing the power and intelligence of the network. As a Preferred Solution Developer, Vyopta has worked closely with Cisco to deliver enhanced solutions that deliver greater interoperability with Cisco networking solutions. Vyopta also shares Cisco’s strong commitment to customer service and satisfaction, has completed interoperability verification testing based on criteria set forth by Cisco, and can provide their customers comprehensive support. With Vyopta products, customers can more quickly deploy a broad range of Cisco Compatible business applications, devices, or services that can enhance the capabilities, performance, and management of the Cisco network. For more information on Vyopta interoperability with Cisco, visit http://www.vyopta.com.

“We are proud to have achieved Preferred Solution Developer Partner Status with Cisco,” said Alfredo Ramirez, President and CEO of Vyopta. “Teaming with Cisco further enables customers to benefit from interoperable solutions that transform how they collaborate, sell, educate, deliver patient care, and more.”

About Vyopta Incorporated
Vyopta is the leading developer of applications for video collaboration, enabling operations intelligence, customer service and content publishing automation that unleash the power of interactive video communications. Vyopta enables companies to do more with video – revolutionizing the way they sell, service, communicate and innovate. For more information on Vyopta, visit http://www.vyopta.com.

  • Interoperability testing is designed to simulate typical customer configurations, and does not replace the need for on-site testing in conjunction with actual implementation.

Vyopta and vControl are registered trademarks of Vyopta Incorporated, and the trademarks of the Vyopta family of products are trademarks of Vyopta Incorporated. All other trademarks referenced herein are the property of their respective owners.

Read the full story at http://www.prweb.com/releases/2013/VyoptaCDN/prweb10497051.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tired Couples May Take Each Other For Granted
2. Trustifi Patent 8,341,023 Granted by USPTO and New Patent to be Issued for Postmarked Email
3. Professional Healthcare at Home Offering Geriatric Care Management Services in the San Francisco Bay Area
4. Fast Growing San Francisco Chiropractic Clinic Welcomes New Doctor, Dr. Anthony Gustin
5. Sean Sullivan San Francisco Real Estate New Construction: Discusses ”The Heights” In Pacific Heights, 14 New Luxury Condos
6. Damaka introduces Xabr™, a Native Mobile Video & Collaboration Client for Cisco® Jabber®, CallManager, and TelePresence
7. Paramount Lists Will Be Speaking At The National Postal Forum In San Francisco
8. Using an HRA to Comply with San Francisco's HCSO Requirements - Zane Benefits Publishes Information
9. American Society of Human Genetics to hold 2012 annual meeting, Nov. 6 to 10, in San Francisco
10. San Francisco is Hosting EB-5 Conference July 19, 2012
11. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: